• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源化抗Tac抗体结合位点的剖析

Dissection of the combining site in a humanized anti-Tac antibody.

作者信息

Glaser S M, Vásquez M, Payne P W, Schneider W P

机构信息

Protein Design Labs, Inc., Mountain View, CA 94043.

出版信息

J Immunol. 1992 Oct 15;149(8):2607-14.

PMID:1401898
Abstract

The genetically engineered "humanized" anti-Tac antibody (HAT) has been shown to bind the p55 chain of the human IL-2R with an affinity close to that of the murine anti-Tac. Although the HAT molecule contains all six mouse CDR, it was not known which, and to what extent, each of the CDR contributes to Ag binding. These questions were addressed by constructing a series of variant HAT antibodies, each substituting a single HAT CDR with a heterologous CDR. The association constants of the variant HAT antibodies to p55 were determined by competitive binding analysis. We find that CDR 1 and 3 of the H chain and CDR 3 of the L chain are essential for maintaining binding. The remaining three CDR appear to be involved to a lesser degree.

摘要

基因工程“人源化”抗 Tac 抗体(HAT)已被证明能以接近鼠抗 Tac 的亲和力与人白细胞介素 -2 受体(IL -2R)的 p55 链结合。尽管 HAT 分子包含所有六个小鼠互补决定区(CDR),但尚不清楚每个 CDR 对抗原结合的贡献程度以及具体是哪些 CDR 起作用。通过构建一系列变体 HAT 抗体来解决这些问题,每个变体 HAT 抗体用一个异源 CDR 替换单个 HAT CDR。通过竞争性结合分析确定变体 HAT 抗体与 p55 的结合常数。我们发现重链的 CDR1 和 CDR3 以及轻链的 CDR3 对于维持结合至关重要。其余三个 CDR 的参与程度似乎较小。

相似文献

1
Dissection of the combining site in a humanized anti-Tac antibody.人源化抗Tac抗体结合位点的剖析
J Immunol. 1992 Oct 15;149(8):2607-14.
2
Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.人源化Mik beta 1,一种针对白细胞介素-2受体β链的人源化抗体,可与人源化抗TAC协同作用。
J Immunol. 1993 Jul 15;151(2):1075-85.
3
X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.人源化抗p185HER2抗体4D5三种变体抗原结合域的X射线结构及与分子模拟的比较。
J Mol Biol. 1993 Feb 20;229(4):969-95. doi: 10.1006/jmbi.1993.1099.
4
Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys.食蟹猴体内人源化抗Tac的免疫原性降低及药代动力学改善
J Immunol. 1991 Aug 15;147(4):1352-9.
5
Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.通过基于结构的抗原结合位点嫁接实现高稳定性单链抗体的人源化
Mol Immunol. 2008 May;45(9):2474-85. doi: 10.1016/j.molimm.2008.01.016. Epub 2008 Mar 3.
6
Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.通过指导选择一种泛癌特异性抗体发现,原始鼠源抗体与其人源等效抗体之间具有相似的结合特性,但结构存在差异。
J Mol Biol. 2000 Feb 25;296(3):833-49. doi: 10.1006/jmbi.2000.3512.
7
IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.白细胞介素-2受体α链(IL-2Rα)导向的单克隆抗体通过一种不同于阻断白细胞介素-2/白细胞介素-2受体α链(IL-2/IL-2Rα)相互作用的机制,在成人T细胞白血病小鼠模型中提供有效的治疗。
Cancer Res. 2000 Dec 15;60(24):6977-84.
8
Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation.对IL-2和IL-15介导的增殖均具有抑制作用的双特异性人源化抗IL-2受体αβ抗体。
J Immunol. 1997 Aug 1;159(3):1543-56.
9
Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.通过同时优化框架区和互补决定区残基对鼠单克隆抗体进行人源化。
J Mol Biol. 1999 Nov 19;294(1):151-62. doi: 10.1006/jmbi.1999.3141.
10
Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.嵌合B72.3抗体的框架残基71和93是重链高变环构象的主要决定因素。
J Mol Biol. 1995 Oct 27;253(3):385-90. doi: 10.1006/jmbi.1995.0560.

引用本文的文献

1
Antibody numbering schemes: advances, comparisons and tools for antibody engineering.抗体编号方案:抗体工程的进展、比较及工具
Protein Eng Des Sel. 2025 Jan 10;38. doi: 10.1093/protein/gzaf005.
2
A comprehensive comparison between camelid nanobodies and single chain variable fragments.骆驼科纳米抗体与单链可变片段的全面比较。
Biomark Res. 2021 Dec 4;9(1):87. doi: 10.1186/s40364-021-00332-6.